
Leo I. Gordon
Professor, Feinberg School of Medicine · Feinberg School of Medicine
Credentials: · · · · ·
History
Present
- Until 1979
- Until 1978
- Until 1976
Research
The Lancet · 2020 · 2,058 citations
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
New England Journal of Medicine · 2022 · 1,350 citations
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Cell · 2017 · 918 citations

94 papers

61 papers · 1 as a fellow

44 papers

43 papers
- AZ
33 papers
- MT
31 papers

31 papers
- MC
30 papers
Grants
- 1997–2000
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $198.4K · Northwestern University
- 1998–2000
Modulation of Post Bmt Lung Injury by Captopril
National Cancer Institute · R03
Contact PI · $148K · Northwestern University
- 1991–1995
Aids Related Lymphomas--Clinical and Biologic Studies
National Cancer Institute · R01
Contact PI · $958K · Northwestern University
Clinical trials
- 2011–2020
Principal investigator · Completed · Phase 2
Northwestern University
- 2010–2014
Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
- 2007–2011
- 2007–2013
Principal investigator · Completed · Phase 2
Northwestern University



